• iTeos Therapeutics SA, of Gosselies, Belgium, said it raised €3 million (US$3.9 million) in a Series A round from the Ludwig Institute for Cancer Research (LICR), Hunza Ventures SCA, Life Sciences Research Partners, VIVES Louvain Technology Fund and several business angels.